1d
News Medical on MSNMaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessmentsMaxCyte, Inc., a leading, cell-engineering focused company providing solutions to advance the discovery, development and commercialization of next-generation cell therapeutics announced today the ...
We recently compiled a list of the 10 Extreme Dividend Stocks to Invest in Now. In this article, we are going to take a look ...
Once you’ve determined a problem, define the specific outcome you aim to achieve by implementing technology—like increasing ...
Lynx Dx, a leader in innovative diagnostic solutions, announced today that its pioneering MyProstateScore 2.0 (MPS2) will be ...
We recently compiled a list of the 12 Best Dividend Stocks Under $30. In this article, we are going to take a look at where Dynex Capital, Inc. (NYSE:DX) stands against the other dividend stocks under ...
TD Bank's global head of FX and emerging market strategy, Mark McCormick, joins Catalysts to discuss the performance of the ...
Montevideo, Minn.-based Integral dx, Inc. recently released a line of customizable Tier 4 switchers “in response to sold ...
MaxCyte (MXCT) announced the acquisition of SeQure Dx. By integrating SeQure Dx into MaxCyte, Maxcyte will expand its service offerings and ...
Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results